OSE Immunotherapeutics
is a France-based biotechnology company that researches and develops immunotherapies for the treatment of cancer and autoimmune diseases... Read moreOSE Immunotherapeutics
is a France-based biotechnology company that researches and develops immunotherapies for the treatment of cancer and autoimmune diseases... Read more
News
Partnership
Apr 30, 2025
Marketscreener
Ose Immunotherapeutics Sa Reports on an Oral Presentation from Research Collaboration with the Leon Berard Cancer Center At the American Association for Cancer Research Annual Meeting Held April 25 - 30, 2025
AI
Jan 30, 2025
FinanzNachrichten
OSE (PAR: OSE) launches AI immunotherapy partnership
Leadership Change
Jun 19, 2024
MarketScreener
Nicolas Poirier joined OSE Immunotherapeutics as Director
OSE Immunotherapeutics Competitors
1
2
3
4
5
6
7
8
9
10